Cleared Traditional

K833656 - NARCOTRACE 40 - NT40 (FDA 510(k) Clearance)

Class I Cardiovascular device.

K833656 · Narco Bio-Systems · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1984
Decision
202d
Days
Class 1
Risk

K833656 is an FDA 510(k) clearance for the NARCOTRACE 40 - NT40. Classified as Recorder, Paper Chart (product code DSF), Class I - General Controls.

Submitted by Narco Bio-Systems (Mchenry, US). The FDA issued a Cleared decision on May 9, 1984 after a review of 202 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2810 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Narco Bio-Systems devices

Submission Details

510(k) Number K833656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 20, 1983
Decision Date May 09, 1984
Days to Decision 202 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 125d · This submission: 202d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DSF Recorder, Paper Chart
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 870.2810
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.